Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
In this study, we investigate the changes of the expression of alpha adrenergic receptor in
the prostate tissue during 2-yr medication period in the man with benign prostatic
hyperplasia. And we also evaluate the efficacy and safety of 24 mo-treatment with doxazosin
(4mg, 8mg)